DocWire News Editors

DocwireNews

Research that has recently emerged from scientists at Massachusetts General Hospital (MGH) that may help combat <a href="https://www.docwirenews.com/docwire-pick/home-page-picks/homepage-round-up-having-a-family-history-of-alzheimers-disease-alters-cognition-concussion-affects-employment-status-and-more/">Alzheimer&rsquo;s disease</a> progression. This work emphasized preventing the brain tissue inflammation that leads to symptoms associated with the disease. The MGH team&rsquo;s findings were recently published online in the journal <a href="https://www.cell.com/neuron/fulltext/S0896-6273(19)30560-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627319305604%3Fshowall%3Dtrue">Neuron</a>.Alzheimer&rsquo;s disease is characterized by deposits of damaged nerve cells and proteins known as <a href="https://www.docwirenews.com/latest-neurology-news/association-of-amyloid-and-tau-with-cognition-in-preclinical-alzheimer-disease-a-longitudinal-study/">amyloid plaques</a>, and by tau protein entanglements. These plaques and tangles usually won&rsquo;t cause Alzheimer&rsquo;s for a long time if they ever do, according to neuroscientist Rudolph E. Tanzi, PhD, director of the Genetics and Aging Research Unit at MGH. Tanzi was also the senior author of the publication. He claims that the inflammation in the brain associated to these tangles and plaques is what primarily kills neurons and causes cognitive decline.In 2008, Tanzi and colleagues uncovered the first gene associated with brain inflammation and Alzheimer&rsquo;s, known as CD33. This gene codes for receptors on microglia cell that normally function to clear neurological debris like these tangles and amyloid plaques.Tanzi and his associates published their discovery of CD33 in 2013, detailing it&rsquo;s influence on microglia activity. They found that high CD33 expression induces the microglia to kill neurons rather than simply clear debris. This over-aggression leads to the neuroinflammation seen in Alzheimer&rsquo;s.Other work has found a counteracting gene to CD33, known as TREM2. This gene inhibits the microglia&rsquo;s ability to cause neuroinflammation, opposing the agonistic action of CD33.&ldquo;The Holy Grail in this field has been to discover how to turn off neuroinflammation in microglia,&rdquo; says Tanzi.Alongside Ana Griciuc, PhD and others, Tanzi set out to identify the interaction between CD33 and TREM2, being that setting a balance between the two genes&rsquo; regulations could be key in combatting Alzheimer&rsquo;s. To analyze each gene, they silenced them both individually and together to observe the effect.Using mouse models of Alzheimer&rsquo;s, the team began by turning off the CD33 gene in a sample of the mice. Tanzi and the team noted that these mice not only had lower levels of amyloid plaque built up in their brains, but that they outperformed the other Alzheimer&rsquo;s mice on memory and learning tests. These tests involve having the mice navigate through a maze.When both the CD33 and TREM2 genes were silenced, however, these neurological and cognitive benefits ceased. The same effect was observed when the researchers only turned off the TREM2 gene.&ldquo;That tells us that TREM2 is working downstream of CD33 to control neuroinflammation,&rdquo; says Tanzi.In sequencing the microglia RNA, the researchers found that both the CD33 and TREM2 genes regulate inflammation by manipulating activity of IL-1 and IL-1RN. IL-1 beta is an immune cell involved in the inflammatory response, and IL-1RN is its receptor.&ldquo;We are increasingly realizing that to help Alzheimer&rsquo;s patients, it is most critical to stop the massive brain nerve cell death that is caused by neuroinflammation,&rdquo; concludes Tanzi. &ldquo;We now see that the CD33 and TREM2 genes are the best drug targets for achieving this goal.&rdquo;<blockquote class="twitter-tweet">
The Neuroscience of Genes and Alzheimer&rsquo;s Neuroinflammation 
Discovery of genomic &ldquo;crosstalk&rdquo; with brain inflammation in Alzheimer&rsquo;s disease.<a href="https://t.co/oP2KXOvYSl">https://t.co/oP2KXOvYSl</a>
&mdash; DementiaJourneys (@DementiaJourney) <a href="https://twitter.com/DementiaJourney/status/1149557764340891650?ref_src=twsrc%5Etfw">July 12, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

How Genetic Interaction Plays into Alzheimer's Disease Inflammation

Future of Medicine

Research that has recently emerged from scientists at Massachusetts General Hospital (MGH) that may help combat Alzheimer’s disease progression. This work emphasized ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe